Oxetanes
![eMolecules 2241107-29-7 | (S)-Oxetane-2-carboxylic acid | Ambeed102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 761013352](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000164809.jpg-250.jpg)
eMolecules 2241107-29-7 | (S)-Oxetane-2-carboxylic acid | Ambeed102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 761013352
(S)-Oxetane-2-carboxylic acid | Ambeed | 2241107-29-7102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 761013352
eMolecules 39267-79-3 | 3-Bromo-oxetane | J & W PharmLab LLC | MFCD08544402 | 136.976 | C3H5BrO | 96.000 | BrC1COC1 | 500mg | 525273023
3-Bromo-oxetane | J & W PharmLab LLC | 39267-79-3 | MFCD08544402 | 136.976 | C3H5BrO | 96.000 | BrC1COC1 | 500mg | 525273023
![eMolecules 84060-09-3 | Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | Combi-Blocks | MFCD10566067 | 218.256 | C12H14N2O2 | 95.000 | O=C1Nc2ccccc2C2(CCNCC2)O1 | 1g | 335354154](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502192561.JPG-250.jpg)
eMolecules 84060-09-3 | Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | Combi-Blocks | MFCD10566067 | 218.256 | C12H14N2O2 | 95.000 | O=C1Nc2ccccc2C2(CCNCC2)O1 | 1g | 335354154
Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | Combi-Blocks | 84060-09-3 | MFCD10566067 | 218.256 | C12H14N2O2 | 95.000 | O=C1Nc2ccccc2C2(CCNCC2)O1 | 1g | 335354154
eMolecules 26272-85-5 | 3-Iodooxetane | ChemScene | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 25g | 536858701
3-Iodooxetane | ChemScene | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 25g | 536858701
eMolecules 21635-88-1 | OXETAN-3-AMINE | AstaTech | MFCD08544363 | 73.095 | C3H7NO | 95.000 | NC1COC1 | 5g | 200612574
OXETAN-3-AMINE | AstaTech | 21635-88-1 | MFCD08544363 | 73.095 | C3H7NO | 95.000 | NC1COC1 | 5g | 200612574
eMolecules 114012-41-8 | Oxetane-3-carboxylic acid | Synthonix - Stock | MFCD08669505 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1COC1 | 5g | 452568566
Oxetane-3-carboxylic acid | Synthonix - Stock | 114012-41-8 | MFCD08669505 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1COC1 | 5g | 452568566
Medchemexpress LLC Purfalcamine 5mg | 1038620-68-6 | 528.62 g/mol | C29H33FN8O | 5 MG
Purfalcamine is a research-grade small molecule inhibitor of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) with reported antimalarial activity. It is intended for laboratory research use only and is used in biochemical and cellular assays to investigate parasite kinase function.
- Selective inhibitor of PfCDPK1 for antimalarial research.
- Reported purity of 99.44% suitable for in vitro assays.
- Available as a solid (multiple sizes, including 5 mg) and as a 10 mM solution in DMSO.
- Molecular weight 528.62 g/mol; molecular formula C29H33FN8O.
- Provided for research use only; not for human or clinical applications.
eMolecules 1374014-30-8 | 3-Bromomethyl-oxetane | J & W PharmLab LLC | MFCD20278240 | 151.003 | C4H7BrO | 96.000 | BrCC1COC1 | 250mg | 495793024
3-Bromomethyl-oxetane | J & W PharmLab LLC | 1374014-30-8 | MFCD20278240 | 151.003 | C4H7BrO | 96.000 | BrCC1COC1 | 250mg | 495793024
eMolecules 21635-88-1 | 3-Aminooxetane | Oakwood Chemical | MFCD08544363 | 73.095 | C3H7NO | 0.000 | NC1COC1 | 1g | 816506303
3-Aminooxetane | Oakwood Chemical | 21635-88-1 | MFCD08544363 | 73.095 | C3H7NO | 0.000 | NC1COC1 | 1g | 816506303
eMolecules 864373-47-7 | oxetane-2-carboxylic acid | Pharmablock | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 250mg | 551170780
oxetane-2-carboxylic acid | Pharmablock | 864373-47-7 | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 250mg | 551170780
eMolecules 864373-47-7 | Oxetane-2-carboxylic acid | Advanced ChemBlocks | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 250mg | 199465714
Oxetane-2-carboxylic acid | Advanced ChemBlocks | 864373-47-7 | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 250mg | 199465714
Medchemexpress LLC Zinc05007751 | 591239-68-8 | 99.3% | 50 MG
ZINC05007751 is a research-grade small-molecule inhibitor of NIMA-related kinase 6 (NEK6) with a reported IC50 of approximately 3.4 μM. It exhibits antiproliferative activity across multiple human cancer cell lines and has reported synergistic effects with cisplatin and paclitaxel in BRCA2-mutated ovarian cancer models. The compound has formula C18H12N2O3, molecular weight 304.30 g/mol, and listed purity 99.33%.
- Inhibits NEK6 with an IC50 of ~3.4 μM.
- Shows antiproliferative activity in various human cancer cell lines.
- Reported synergy with cisplatin and paclitaxel in BRCA2-mutated ovarian cancer models.
- High purity, suitable for research applications.
- Supplied as a 50 mg research pack; soluble in DMSO.
eMolecules 21635-92-7 | Ambeed | 4-Methylpyridine-26-dicarbonitrile | 250mg | 783629730 | A1388465 | MFCD00956145 | 143.149 | C8H5N3
Ambeed | 4-Chloro-2-fluoro-1-methoxybenzene | 1g | 600832861 | A185766 | 452-09-5 | MFCD00672964 | 160.570 | C7H6ClFO
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
![eMolecules 77211-75-7 | Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate | Combi-Blocks | MFCD11976640 | 247.294 | C14H17NO3 | 98.000 | O=C(OCc1ccccc1)N1CCC2(CO2)CC1 | 25g | 415498225](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502192082.JPG-250.jpg)
eMolecules 77211-75-7 | Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate | Combi-Blocks | MFCD11976640 | 247.294 | C14H17NO3 | 98.000 | O=C(OCc1ccccc1)N1CCC2(CO2)CC1 | 25g | 415498225
Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate | Combi-Blocks | 77211-75-7 | MFCD11976640 | 247.294 | C14H17NO3 | 98.000 | O=C(OCc1ccccc1)N1CCC2(CO2)CC1 | 25g | 415498225